![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
JP O'Callaghan and SG Holtzman
The analgesic activity of morphine and the narcotic antagonists, pentazocine, cyclazocine, levallorphan and nalorphine, was assessed in the rat using two hot plates: one maintained at 49.5 degrees C and the other at the "standard" 54.5 degrees C. The analgesic effects of morphine using the 49.5 degrees C hot plate were of a significantly greater magnitude than its effects using the 54.5 degrees C hot plate for both nontolerant and morphine-tolerant subjects. Dose-related effects were observed with all of the narcotic antagonists tested using the 49.5 degrees C hot plate; only the highest dose of pentazocine exhibited activity using the 54.5 degrees C hot plate. Naloxone (3.0 mg/kg) antagonized the analgesic effects of morphine and all of the narcotic antagonists, but was without activity itself when tested using the 49.5 degrees C hot plate at doses as high as 30 mg/kg. Aspirin was also inactive using the 49.5 degrees C plate, whereas physostigmine increased latencies only at a dose that produced severe motor deficit. A low temperature hot plate is recommended for evaluating the analgesic activity of narcotic antagonists in the rat. This simple procedure provides results which are dose-related, quantifiable, reproducible, of a large magnitude and specific.
This article has been cited by other articles:
|
|
 |
|
  T. V. Khroyan, N. T. Zaveri, W. E. Polgar, J. Orduna, C. Olsen, F. Jiang, and L. Toll SR 16435 [1-(1-(Bicyclo[3.3.1]nonan-9-yl)piperidin-4-yl)indolin-2-one], a Novel Mixed Nociceptin/Orphanin FQ/{micro}-Opioid Receptor Partial Agonist: Analgesic and Rewarding Properties in Mice J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 934 - 943. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. E. Codd, J. R. Carson, R. W. Colburn, S. L. Dax, D. Desai-Krieger, R. P. Martinez, L. A. McKown, L. A. Neilson, P. M. Pitis, P. L. Stahle, et al. The Novel, Orally Active, Delta Opioid RWJ-394674 Is Biotransformed to the Potent Mu Opioid RWJ-413216 J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1273 - 1279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. H. Huntjens, M. Danhof, and O. E. Della Pasqua Pharmacokinetic pharmacodynamic correlations and biomarkers in the development of COX-2 inhibitors Rheumatology, July 1, 2005; 44(7): 846 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Warnecke, H. Oster, J.-P. Revelli, G. Alvarez-Bolado, and G. Eichele Abnormal development of the locus coeruleus in Ear2(Nr2f6)-deficient mice impairs the functionality of the forebrain clock and affects nociception Genes & Dev., March 1, 2005; 19(5): 614 - 625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. A. Rasmussen and L. A. Farr Effects of Morphine and Time of Day on Pain and Beta-Endorphin Biol Res Nurs, October 1, 2003; 5(2): 105 - 116. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Bonabello, M. R. Galmozzi, R. Canaparo, G. C. Isaia, L. Serpe, E. Muntoni, and G. P. Zara Dexibuprofen (S(+)-Isomer Ibuprofen) Reduces Gastric Damage and Improves Analgesic and Antiinflammatory Effects in Rodents Anesth. Analg., August 1, 2003; 97(2): 402 - 408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Le Bars, M. Gozariu, and S. W. Cadden Animal Models of Nociception Pharmacol. Rev., December 1, 2001; 53(4): 597 - 652. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Chrast, H. S. Scott, R. Madani, L. Huber, D. P. Wolfer, M. Prinz, A. Aguzzi, H.-P. Lipp, and S. E. Antonarakis Mice trisomic for a bacterial artificial chromosome with the single-minded 2 gene (Sim2) show phenotypes similar to some of those present in the partial trisomy 16 mouse models of Down syndrome Hum. Mol. Genet., July 22, 2000; 9(12): 1853 - 1864. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Morgan, C. D. Cook, and M. J. Picker Sensitivity to the Discriminative Stimulus and Antinociceptive Effects of µ Opioids: Role of Strain of Rat, Stimulus Intensity, and Intrinsic Efficacy at the µ Opioid Receptor J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 965 - 975. [Abstract] [Full Text]
|
|
|
|
|
|
D. Morgan, C. D. Cook, M. A. Smith, and M. J. Picker An Examination of the Interactions Between the Antinociceptive Effects of Morphine and Various {micro}-Opioids: The Role of Intrinsic Efficacy and Stimulus Intensity Anesth. Analg., February 1, 1999; 88(2): 407 - 407. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ghelardini, N. Galeotti, F. Gualtieri, V. Marchese, C. Bellucci, and A. Bartolini Antinociceptive and Antiamnesic Properties of the Presynaptic Cholinergic Amplifier PG-9 J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 806 - 816. [Abstract] [Full Text]
|
|
|
|
|
|
H. R. Garner, T. F. Burke, C. D. Lawhorn, J. M. Stoner, and W. D. Wessinger Butorphanol-Mediated Antinociception in Mice: Partial Agonist Effects and Mu Receptor Involvement, J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1253 - 1261. [Abstract] [Full Text]
|
|
|
|
|
|
C. Ghelardini, N. Galeotti, F. Gualtieri, C. Bellucci, D. Manetti, A. Giotti, P. Malmberg-Aiello, A. Galli, and A. Bartolini Antinociceptive Profile of 3-alpha -tropanyl-(2-Cl)-acid phenoxybutyrate (SM-21): A Novel Analgesic with a Presynaptic Cholinergic Mechanism of Action J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 430 - 439. [Abstract] [Full Text]
|
|
|
|
|
|
N. Galeotti, C. Ghelardini, L. Papucci, S. Capaccioli, A. Quattrone, and A. Bartolini An Antisense Oligonucleotide on the Mouse Shaker-like Potassium Channel Kv1.1 Gene Prevents Antinociception Induced by Morphine and Baclofen J. Pharmacol. Exp. Ther., May 1, 1997; 281(2): 941 - 949. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
